Literature DB >> 9368997

Preventative programs for respiratory disease in cow/calf operations.

T J Engelken1.   

Abstract

Control of respiratory disease in cow/calf operations presents many challenges. The incidence of disease in the suckling calf is not well documented and the logistics of handling range animals make control programs difficult to implement. Health programs have to be built around normal working patterns, and these patterns may not provide the best "fit" for immune management of the calf. Weaned calves undergo significant disease challenge when they enter typical marketing channels. This provides the potential for high levels of calf morbidity, mortality, medicine costs, and losses from decreased performance as they arrive at a stocker operation or feedyard. If preweaning calf health and preconditioning programs are used, they must be planned so that the producer has an opportunity to obtain a return on their investment. Options for increasing calf weight marketed, certified calf health sales, or retained ownership through the next phase of production should be evaluated carefully. Any potential increase in calf value must be weighed against program costs. This affords the veterinarian an opportunity to build on traditional disease management and prevention skills and expand their influence in overall ranch management.

Entities:  

Mesh:

Year:  1997        PMID: 9368997     DOI: 10.1016/s0749-0720(15)30316-9

Source DB:  PubMed          Journal:  Vet Clin North Am Food Anim Pract        ISSN: 0749-0720            Impact factor:   3.357


  2 in total

1.  Bovine respiratory disease: commercial vaccines currently available in Canada.

Authors:  S L Bowland; P E Shewen
Journal:  Can Vet J       Date:  2000-01       Impact factor: 1.008

2.  Effect of a quadrivalent vaccine against respiratory virus on the incidence of respiratory disease in weaned beef calves.

Authors:  George Stilwell; Miguel Matos; Nuno Carolino; Miguel S Lima
Journal:  Prev Vet Med       Date:  2008-04-18       Impact factor: 2.670

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.